NEW YORK--(BUSINESS WIRE)--The original form 10-K filed by Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company for the year ended December 31, 2005 included restatements and reclassifications for the comparative years ended December 31, 2004 and 2003. Changes in accounting principles and segment reporting which necessitated these restatements and reclassifications were fully disclosed in the original filing.
